Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Abbott Laboratories Inc.is launching a new portable point-of-care test that can detect COVID-19 within five minutes, the company announced on March 27.
The new test, ID NOW COVID19, will run on Abbott’s portable POC platform ID NOW and deliver positive results in as little as five minutes, the company says. Negative results are delivered in thirteen minutes.
The test has been issued an emergency use authorization (EUA) by the US Food and Drug Administration and is expected to be available in the US this week.
As the pandemic unfolds, there have been repeated calls to increase availability of rapid testing. POC tests such as Abbott’s ID NOW may play an important role in diagnosing infection, but the sensitivity and specificity of these rapidly developed tests are also being questioned.
It is the second COVID-19 test to receive an EUA. Last week Abbott launched the Abbott m2000 RealTime SARS-CoV-2 test. Between the two platforms, Abbott said it expects to produce about 5 million tests per month. (Also see "Abbott Receives Emergency Use Authorization For COVID-19 Test" - Medtech Insight, 19 Mar, 2020.)
[Editor’s note:Medtech Insight is tracking the global diagnostic pipeline of COVID-19 tests. See ourCOVID-19 test trackerfor a full listing.]
Medtech Insight: global medical technology news & analysis
By Elizabeth Orr 18 Sep 2020
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its...
Medtech Insight: global medical technology news & analysis
18 Sep 2020
The US FDA has been skeptical about remote testing, but independent consultant (and former Abbott human factors director) Ed Israelski...
In Vivo: strategic insights for life sciences decision-maker...
Explore how digital technologies are being used to address the disruption of clinical trials for drugs and medical technology caused by COVID-19. Stay current with insights from industry leaders, information on guidance and regulation, and an examination of how the challenges of this global crisis and the industry’s response to it may soon usher in a new era in worldwide healthcare.
Topics Coronavirus
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Looking for more products Product Finder
